Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
February 12, 2013
Patent Application Number
12554194
Date Filed
September 4, 2009
Patent Citations Received
Patent Primary Examiner
Patent abstract
The present application describes antibody formulations, including monoclonal antibodies formulated in histidine-acetate buffer, as well as a formulation comprising an antibody that binds to domain II of HER2 (for example, Pertuzumab), and a formulation comprising an antibody that binds to DR5 (for example, Apomab).
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
